Webinar: navigating complexity in CAR-T therapy delivery

ATMP Denmark invites you to an upcoming webinar on how hospitals can navigate the growing complexity of delivering CAR-T therapies – from certification requirements to clinical practice.

As CAR T-cell therapies continue to transform patient care, hospitals face increasing complexity in delivering these treatments safely, effectively, and in compliance with regulatory requirements.

Why it matters
CAR-T therapies are not simply administered like many conventional medicines like small molecules and biologics. They involve a complex treatment pathway.

Before Danish hospitals can offer authorised CAR-T therapies, they must meet extensive certification, training, documentation, and quality requirements. While these measures are essential for ensuring patient safety, quality, and traceability, they can also create significant administrative and operational burdens in clinical practice.

The challenge
Many CAR-T products follow similar clinical pathways, yet certification, training, audits, electronic systems, and documentation requirements are often managed separately for each individual product. This can result in overlapping processes across clinical teams, pharmacies, laboratories, and hospitals.

What we will discuss
In this webinar, we will explore how growing regulatory and product-specific requirements impact CAR-T programs in Denmark and experience across Europe.

Together with experts from clinical practice, we will discuss opportunities for greater coordination and streamlined approaches that maintain the highest standards of patient safety, quality, and compliance while reducing unnecessary administrative burden.

The webinar is relevant for clinicians, industry, authorities and other stakeholders working with CAR-T and advanced therapies.

Programme and registration will follow.